Arterial chemoreceptors and sympathetic nerve activity: implications for hypertension and heart failure.
Harold D Schultz, Yu L Li, Yanfeng Ding
https://pubmed.ncbi.nlm.nih.gov/17502495/Actively Recruiting
Led by University of Calgary · Updated on 2026-05-05
80
Participants Needed
1
Research Sites
21 weeks
Total Duration
This research aims to understand and find new ways to treat Neurogenic Orthostatic Hypotension NOH, a condition where the bodys automatic nervous system fails to maintain blood pressure when standing. This failure can cause symptoms like light-headedness, nausea, and fainting due to reduced blood flow and oxygen to the brain. The study explores how breathing higher levels of carbon dioxide might help improve blood pressure and brain blood flow in people with NOH, comparing responses between male and female patients and healthy controls. Participants will breathe different levels of carbon dioxide during a series of standing tests while researchers monitor their heart rate, blood pressure, and brain blood flow using advanced imaging called functional Optical Coherence Tomography fOCT. Five stand tests involve breathing normal air, baseline carbon dioxide, and increased levels 5 mmHg, 10 mmHg, and 10 mmHg CO2 with 50 mmHg oxygen using a computerized gas delivery system. Recovery periods follow each test to return breathing to normal. The study will also include a rebreathing task to trigger changes in carbon dioxide and oxygen levels. Participants will undergo detailed monitoring of blood pressure, heart rate, stroke volume, and symptoms during each test, along with breath-by-breath measurements of oxygen and carbon dioxide levels and breathing patterns. OCT images will track blood flow in eye vessels as a measure of nervous system and brain blood flow control. The main outcome measured is the change in blood pressure between sitting and standing with and without increased carbon dioxide. The study will also look at symptom changes and brain blood flow velocity. The total participation time and follow-up details are based on these tests and assessments.
CONDITIONS
Hypercapnia in Orthostatic Hypotension
J
Jacquie Baker, PhD
R
Rasha Hamzeh, RN
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University of Calgary
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Participants will be assessed to confirm they meet criteria including age, smoking status, and ability to participate safely.
Duration - Single visit with multiple testing conditions in one session
Participants complete five Active Stand Tests involving breathing different levels of CO2 and oxygen to assess effects on blood pressure, orthostatic symptoms, and cerebrovascular responses using functional OCT imaging.
1 in-person visit during which participants undergo five sequential breathing conditions with recovery periods between each
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
TREATMENT
Number of Arms
5
Have more questions? Get in touch with our team for quick support
Harold D Schultz, Yu L Li, Yanfeng Ding
https://pubmed.ncbi.nlm.nih.gov/17502495/Jacquie R Baker, Shaun I Ranada, Anthony V Incognito...
https://pubmed.ncbi.nlm.nih.gov/41734601/Reuben Howden, J Timothy Lightfoot, Stephen J Brown...
https://pubmed.ncbi.nlm.nih.gov/15131068/B J Morgan, D C Crabtree, M Palta...
https://pubmed.ncbi.nlm.nih.gov/7559221/J K Shoemaker, D D O'Leary, R L Hughson
https://pubmed.ncbi.nlm.nih.gov/11514269/Roy Freeman, Wouter Wieling, Felicia B Axelrod...
https://pubmed.ncbi.nlm.nih.gov/21431947/Roy Freeman, Ahmad R Abuzinadah, Christopher Gibbons...
https://pubmed.ncbi.nlm.nih.gov/30190008/University of Calgary
Lead Sponsor